Hyperlipemia
Conditions
Interventions
Dietary therapy + Red Koji
Dietary therapy
Sponsors
Graduate School of Medicine, Chiba University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)People with LDL-cholesterol level of 140 and over mg/dL without the past of a coronary artery disease 2)patients under an enforcement schedule or enforcement of dietary therapy for hypercholesterolemia 3)Age >=20 years, <80 years (Male and Female) 4)A consent form for participating in this study is submitted
Exclusion criteria
Exclusion criteria: 1)Patients with familial hypercholesterolemia or with LDL-cholesterol level of 180 and over mg/dL 2)People with rice allergy, and people who have resistance in eating rice 3)Patients taking statin drugs within 4 weeks (or Probucol within 8 weeks) in the past 4)Patients with type 1 diabetes or diabetic patients with HbA1c level of over 8% 5)Patients with sever diseases other than diabetes, such as liver disease, a renal disease, and cardiac disease 6)Patients with the past, such as a food allergy, idiosyncrasy, and alcoholism 7)People who participated in other clinical trials within the past three months before the start of this clinical trial, or who have participated in other clinical trials at the start of this clinical trial 8)Patients who are pregnant, breastfeeding or intention to becoming pregnant 9)Patients whose LDL-cholesterol level became less than 140 mg/dL by dietary therapy of period I or patients with TG level of 400 and over mg/dL 10)Patients judged unsuitable by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of LDL-C from the baseline to 4 and 8 weeks later | — |
Countries
Japan
Contacts
Public ContactKazuki Kobayashi
Graduate School of Medicine, Chiba University Clinical Cell Biology and Medicine
Outcome results
None listed